Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBI-001 in Interdigital Tinea Pedis
NCT04315051Phase 2Terminated
- Sponsor
- DermBiont, Inc.
- Start
- Sep 2019
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in interdigital tinea pedis (TP) (2 arms), sponsored by DermBiont, Inc. Primary endpoint: From Culture Positive to Culture Negative at Day 28. Started Sep 2019; status: terminated.
02
Conditions
interdigital tinea pedis (TP)
Beyond the preview
Go deeper on NCT04315051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04315051.